Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Aging alters synergistic microRNA networks in exosomes to stimulate repair in lung injury and skin wound healing

Elliot SJ., Grimaldo S., Catanuto P., Pereira-Simon S., Xia X., Civettini G.

Laboratory Study on Chronic Wound, published in Mol Ther Nucleic Acids (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mol Ther Nucleic Acids (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42088451
PMCID
PMC13138169
DOI
10.1016/j.omtn.2026.102927

Abstract (original English)

Mesenchymal stem cells (MSCs) deliver their effects via paracrine signaling, including the release of extracellular vesicles (EVs), which transfer microRNAs (miRNAs) and mRNAs to recipient cells. Aging alters exosome composition and function, raising questions about donor age, the use of autologous vs. allogeneic donors, and exosome dose and dosing frequency for exosome-based therapies in fibrotic lung disease. To address these gaps, we investigated how exosomes from younger (28-39 years, adult-exo) and older (58-66 years) donors influence fibrosis and tissue repair. Exosomes were delivered intravenously to 18-months-old male C57BL/6 mice on day 12 post-bleomycin (BLM), with lung injury evaluated on day 21 by histologic, molecular, mitochondrial, and telomere analyses. A human skin injury model was used to quantitate exosome-mediated wound healing. Adult-exo reduced lung injury and accelerated skin wound closure. RNA sequencing (RNA-seq) revealed that adult-exo carried elevated antifibrotic miRNAs, such as let-7. Pathway enrichment linked this cargo to extracellular matrix (ECM) remodeling, mitochondrial function, and senescence. Adult-exo treatment also downregulated fibrosis- and senescence-associated miRNAs, such as miR-34, in lung tissue. In vitro experiments confirmed alterations in multiple downstream pathways, mediating reparative effects. These findings underscore age-d

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research